Can video chats curb drinking in liver patients? new trial aims to find out

NCT ID NCT05191446

Ongoing Disease control Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a stepped alcohol treatment delivered via video or phone calls can help people with advanced liver disease cut back on unhealthy drinking. About 180 participants will be randomly assigned to either the treatment program or usual care. The goal is to see if the program reduces alcohol use and improves liver-related outcomes over 6 to 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: stepped alcohol treatment (motivational interviewing sessions via video or telephone)
What this could lead to: If successful, this could provide an effective way to help people with liver disease reduce harmful drinking using telehealth, potentially improving liver health and quality of life.
What could go wrong: This is a relatively small study (180 participants) and focuses on behavior change, which can be hard to sustain. Results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alcohol abuse liver disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALCOHOL USE DISORDER LIVER DISEASES

Contacts and locations

Locations

University of california San Francisco

San Francisco, California, 94110, United States
Zuckerberg San Francisco General Hospital

San Francisco, California, 94110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.